Royal Orchid Hotels Limited
Financial trend (40/100) does the heavy lifting; momentum (8/100) is the drag.
Fair valueSolvency riskRoyal Orchid Hotels Limited earns a Sell from StocksWizard, with a blended score of 30/100. We put fair value near ₹284.45; at ₹312.85 that leaves roughly 9% downside, so the stock screens fairly valued. On 29.0x trailing earnings it sits roughly in line with the Consumer Cyclical median of about 27.7x. The price is about 44% below its 52-week high of ₹560.95 and 15% above the low of ₹271.3. Financial health scores 2/100, in the distress band on the Altman Z-score, with a Piotroski F-score of 3/9. It clears 2 of 13 investability checks, with durability 32, valuation 40 and momentum 8 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹227.56.
1-year price
EOD · 2026-07-3152-week range
-44.23% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell30Piotroski F-score 3/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 12.8%
- Fail: Low debt (D/E < 0.5): 2.33x
- Pass: Positive free cash flow
- Pass: Revenue growth > 10%: 31%
- Fail: Earnings growing: -39%
- Fail: Net margin ≥ 10%: 8.4%
- Fail: Current ratio > 1.5: 1.22
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 1.06
- Fail: Piotroski ≥ 7: 3/9
Quarterly results
Annual financials
Shareholding
- Promoter68.9%
- Institutions4.3%
- Public & other26.8%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Opportunities
- Revenue growing (31% YoY).
- Well off its 52-week high — possible mean-reversion.
Bear case
Weaknesses
- High debt relative to equity.
- Price below its 200-day moving average (downtrend).
- Weak Piotroski score (3/9).
Threats
- Earnings contracting year on year.
- Balance-sheet stress — Altman Z 1.06.
About Royal Orchid Hotels Limited
Royal Orchid Hotels Limited operates and manages hotels and resorts across India and Tanzania under multiple brands including Regenta, Hotel Royal Orchid, Royal Orchid Suits, Regenta Central, Regenta Resort, Royal Orchid Resort, Royal Orchid Central, Regenta Place, Regenta Z, and Regenta Inn. The company's portfolio includes 5-star and 4-star properties serving business and leisure travelers. It also provides restaurant services.
Royal Orchid Hotels Limited — frequently asked questions
Is Royal Orchid Hotels Limited a buy, hold or sell?
StocksWizard currently rates Royal Orchid Hotels Limited (ROHLTD) a Sell, based on a blended score of 30/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Royal Orchid Hotels Limited's fair value?
Our blended DCF and relative-valuation model estimates Royal Orchid Hotels Limited's fair value at about ₹284.45, versus a current price of ₹312.85 — roughly 9% downside. On that basis the stock looks fairly valued.
Is Royal Orchid Hotels Limited financially healthy?
Royal Orchid Hotels Limited scores 2/100 on our financial-health model, placing it in the distress band on the Altman Z-score, with a Piotroski F-score of 3/9.
How has Royal Orchid Hotels Limited's share price performed?
Royal Orchid Hotels Limited is down 8% over three months, and last traded at ₹312.85. Past performance doesn't predict future returns.
More in Consumer Cyclical
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.